Mobileye Global Inc (MBLY)
NASDAQConsumer DiscretionaryAuto - PartsSnapshot 2026-09-09
$8.10-4.93%
Close 2026-09-09 · 1-day change
NASDAQConsumer DiscretionaryAuto - PartsSnapshot 2026-09-09
Intact: The reason to own it still holds.
Mobileye raised 2026 revenue guidance to about $1.975 billion. Robotaxi deals support growth. Management aims to control losses after a big acquisition. Revenue grew from $446M to $558M in one quarter.
Operating losses rose sharply to nearly $3.9 billion in 2026-Q1. Competition in robotaxis is strong. Managing losses after acquisition is uncertain. Risks could hurt profit and growth.
The price is about 17% above our fair value near $8. Analysts expect 7% revenue growth. Our fair value is below the Street median, so weigh the Street range.
Breaks if: Operating losses worsen beyond -$4 billion in FY26
Breaks if: Full-year 2026 revenue falls below $1.9 billion
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround play with a focus on improving fundamentals. Currently, the thesis is under pressure due to recent weak financial performance and elevated risks in the Consumer Discretionary sector.
The market appears to have priced in a justified valuation, reflecting a low expectations gap. However, MBLY trades at a premium compared to its peers, indicating that some positive performance is already expected.
Management is on track with revenue and adjusted operating income growth, but the company is struggling with significant operating losses due to acquisition-related charges. The near-term risk of missing earnings is low, but the industry has seen peers miss recently, which could impact sentiment.
The thesis hinges on management's ability to maintain revenue guidance and improve operating income while managing losses. Additionally, broader sector performance and inflation trends will be critical factors to watch.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat and increased revenue guidance support the read. However, the CEO change may impact strategic direction and execution.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Raise full-year 2026 revenue guidance midpoint reflecting better-than-expected demand and higher EyeQ unit shipments.
Stated as a priority in 3 of last 3 quarters. Revenue increased 27% year-over-year from $438M in 2025-Q1 to $558M in 2026-Q1. Management raised the full-year 2026 revenue guidance midpoint by 2% to $1,975M reflecting better-than-expected demand. The trajectory is delivering with consistent upward revisions.
“We are confident in Mobileye’s strategy, leadership team, technology platform, customer relationships, and long-term opportunities.”
“We are raising the midpoint of our full-year 2026 revenue guidance by 2% to reflect better-than-expected demand in the first quarter.”
“Full-year 2026 financial guidance implies flat to 5% year-over-year revenue growth.”
Breaks if: Robotaxi revenue growth stalls or declines in FY26
Raise full-year 2026 revenue guidance midpoint reflecting better-than-expected demand and higher EyeQ unit shipments.
Stated as a priority in 3 of last 3 quarters. Revenue increased 27% year-over-year from $438M in 2025-Q1 to $558M in 2026-Q1. Management raised the full-year 2026 revenue guidance midpoint by 2% to $1,975M reflecting better-than-expected demand. The trajectory is delivering with consistent upward revisions.
“We are confident in Mobileye’s strategy, leadership team, technology platform, customer relationships, and long-term opportunities.”
“We are raising the midpoint of our full-year 2026 revenue guidance by 2% to reflect better-than-expected demand in the first quarter.”
“Full-year 2026 financial guidance implies flat to 5% year-over-year revenue growth.”
In the next 1 to 3 years, MBLY's performance will depend on its execution and external economic factors. Not investment advice.